Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SOPHiA GENETICS SA - Ordinary Shares (NQ:SOPH)

4.400 +0.030 (+0.69%)
Streaming Delayed Price Updated: 3:24 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SOPHiA GENETICS SA - Ordinary Shares

< Previous 1 2 3 4 Next >
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
Strong momentum to continue in 2024 as SOPHiA GENETICS announces record revenue, 35 new customer additions in Q4, and 36% cash burn decline in FY 2023 
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
Preview: Sophia Genetics's Earnings
 
Via Benzinga
Earnings Preview: Sophia Genetics
 
Via Benzinga
A Preview Of Sophia Genetics's Earnings
 
Via Benzinga
Earnings Scheduled For March 5, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
Via Benzinga
SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
Top 5 Health Care Stocks That May Crash This Month
As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023
Record results on growth acceleration, significant improvement in operating loss and cash burn 
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2023
Robust growth and efficient expense execution continues 
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2023
Strong growth momentum and efficient expense execution continues 
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
SOPHiA GENETICS’ SOPHiA DDM™ HRD Solution is Tapped by Unipath Specialty Laboratory Limited
From SOPHiA GENETICS
Via Business Wire
SOPHiA GENETICS Celebrates Swiss Biotech Award
From SOPHiA GENETICS
Via Business Wire
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2023 on May 9, 2023
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
The University of Maryland Medical Center Chooses SOPHiA GENETICS Technology
From SOPHiA GENETICS
Via Business Wire
Krsnaa Diagnostics is Live on SOPHiA GENETICS
From SOPHiA GENETICS
Via Business Wire
Tel Aviv Sourasky Medical Center Chooses SOPHiA DDMTM HRD Solution of SOPHiA GENETICS
From SOPHiA GENETICS
Via Business Wire
Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test
From SOPHiA GENETICS
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis
From SOPHiA GENETICS
Via Business Wire
SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results
From SOPHiA GENETICS SA
Via Business Wire
University of Arkansas for Medical Sciences Will Use SOPHiA GENETICS to Advance Clinical Research for Blood Cancers
From SOPHiA GENETICS
Via Business Wire
SOPHiA GENETICS Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
From SOPHiA GENETICS
Via Business Wire
SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing
From SOPHiA GENETICS
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.